Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements

American Journal of Pathology

Volumn 185, Issue 5, 2015, Pages 1297-1303

  Delitto, Daniel ^a   Pham, Kien ^a   Vlada, Adrian C ^a   Sarosi, George A ^a,b   Thomas, Ryan M ^a,b   Behrns, Kevin E ^a   Liu, Chen ^a   Hughes, Steven J ^a   Wallet, Shannon M ^a   Trevino, Jose G ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN;

AGE; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER SURVIVAL; CELL INVASION; CLINICAL ARTICLE; DISEASE SEVERITY; ENGRAFTMENT; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMPLANTATION; LIVER METASTASIS; LYMPH NODE RATIO; METASTASIS POTENTIAL; MOUSE; NONHUMAN; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR ENGRAFTMENT; TUMOR MICROENVIRONMENT; TUMOR VOLUME; TUMOR XENOGRAFT; ADENOCARCINOMA; ANIMAL; DISEASE MODEL; FLUORESCENT ANTIBODY TECHNIQUE; PANCREAS TUMOR; PATHOLOGY; PROCEDURES; SCID MOUSE; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; HETEROGRAFTS; HUMANS; MICE; MICE, SCID; PANCREATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MICROENVIRONMENT;

EID: 84928036917     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.01.016     Document Type: Article

References (16)

1. T.G. Roberts Jr., B.H. Goulart, L. Squitieri, S.C. Stallings, E.F. Halpern, B.A. Chabner, G.S. Gazelle, S.N. Finkelstein, and J.W. Clark Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials JAMA 292 2004 2130 2140
2. J.I. Johnson, S. Decker, D. Zaharevitz, L.V. Rubinstein, J.M. Venditti, S. Schepartz, S. Kalyandrug, M. Christian, S. Arbuck, M. Hollingshead, and E.A. Sausville Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials Br J Cancer 84 2001 1424 1431
3. V.C. Daniel, L. Marchionni, J.S. Hierman, J.T. Rhodes, W.L. Devereux, C.M. Rudin, R. Yung, G. Parmigiani, M. Dorsch, C.D. Peacock, and D.N. Watkins A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro Cancer Res 69 2009 3364 3373
4. J.J. Tentler, A.C. Tan, C.D. Weekes, A. Jimeno, S. Leong, T.M. Pitts, J.J. Arcaroli, W.A. Messersmith, and S.G. Eckhardt Patient-derived tumour xenografts as models for oncology drug development Nat Rev Clin Oncol 9 2012 338 350
5. V. Dangles-Marie, M. Pocard, S. Richon, L.B. Weiswald, F. Assayag, P. Saulnier, J.G. Judde, J.L. Janneau, N. Auger, P. Validire, B. Dutrillaux, F. Praz, D. Bellet, and M.F. Poupon Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features Cancer Res 67 2007 398 407
6. Y.S. DeRose, G. Wang, Y.C. Lin, P.S. Bernard, S.S. Buys, M.T. Ebbert, R. Factor, C. Matsen, B.A. Milash, E. Nelson, L. Neumayer, R.L. Randall, I.J. Stijleman, B.E. Welm, and A.L. Welm Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes Nat Med 17 2011 1514 1520
7. R. Martinez-Garcia, D. Juan, A. Rausell, M. Munoz, N. Banos, C. Menendez, P.P. Lopez-Casas, D. Rico, A. Valencia, and M. Hidalgo Transcriptional dissection of pancreatic tumors engrafted in mice Genome Med 6 2014 27
8. L. Rahib, B.D. Smith, R. Aizenberg, A.B. Rosenzweig, J.M. Fleshman, and L.M. Matrisian Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States Cancer Res 74 2014 2913 2921
9. T. Conroy, F. Desseigne, M. Ychou, O. Bouche, R. Guimbaud, Y. Becouarn, A. Adenis, J.L. Raoul, S. Gourgou-Bourgade, C. de la Fouchardiere, J. Bennouna, J.B. Bachet, F. Khemissa-Akouz, D. Pere-Verge, C. Delbaldo, E. Assenat, B. Chauffert, P. Michel, C. Montoto-Grillot, and M. Ducreux Groupe Tumeurs Digestives of Unicancer, PRODIGE Intergroup: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 2011 1817 1825
10. H.A. Burris 3rd, M.J. Moore, J. Andersen, M.R. Green, M.L. Rothenberg, M.R. Modiano, M.C. Cripps, R.K. Portenoy, A.M. Storniolo, P. Tarassoff, R. Nelson, F.A. Dorr, C.D. Stephens, and D.D. Von Hoff Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 1997 2403 2413
11. D.D. Von Hoff, T. Ervin, F.P. Arena, E.G. Chiorean, J. Infante, M. Moore, T. Seay, S.A. Tjulandin, W.W. Ma, M.N. Saleh, M. Harris, M. Reni, S. Dowden, D. Laheru, N. Bahary, R.K. Ramanathan, J. Tabernero, M. Hidalgo, D. Goldstein, E. Van Cutsem, X. Wei, J. Iglesias, and M.F. Renschler Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine N Engl J Med 369 2013 1691 1703
12. M.J. Moore, D. Goldstein, J. Hamm, A. Figer, J.R. Hecht, S. Gallinger, H.J. Au, P. Murawa, D. Walde, R.A. Wolff, D. Campos, R. Lim, K. Ding, G. Clark, T. Voskoglou-Nomikos, M. Ptasynski, and W. Parulekar Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 25 2007 1960 1966
13. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
14. B. Rubio-Viqueira, A. Jimeno, G. Cusatis, X. Zhang, C. Iacobuzio-Donahue, C. Karikari, C. Shi, K. Danenberg, P.V. Danenberg, H. Kuramochi, K. Tanaka, S. Singh, H. Salimi-Moosavi, N. Bouraoud, M.L. Amador, S. Altiok, P. Kulesza, C. Yeo, W. Messersmith, J. Eshleman, R.H. Hruban, A. Maitra, and M. Hidalgo An in vivo platform for translational drug development in pancreatic cancer Clin Cancer Res 12 2006 4652 4661
15. M. Mattie, A. Christensen, M.S. Chang, W. Yeh, S. Said, Y. Shostak, L. Capo, A. Verlinsky, Z. An, I. Joseph, Y. Zhang, S. Kumar-Ganesan, K. Morrison, D. Stover, and P. Challita-Eid Molecular characterization of patient-derived human pancreatic tumor xenograft models for preclinical and translational development of cancer therapeutics Neoplasia 15 2013 1138 1150
16. M.P. Kim, D.B. Evans, H. Wang, J.L. Abbruzzese, J.B. Fleming, and G.E. Gallick Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice Nat Protoc 4 2009 1670 1680